NEW YORK, Feb. 13 (GenomeWeb News) - The National Cancer Institute launched an initiative to identify genetic susceptibilities to prostate and breast cancer, the National Institutes of Health announced today.
Illumina has been tapped to do rapid genotyping for the project, NIH said, beginning with 2,500 male samples for the prostate cancer portion of the research.
The Cancer Genetic Markers of Susceptibility project is a three-year initiative with $14 million in funding, according to a statement.
The initiative will analyze as many as 500,000 SNPs in each cancer case or control. NCI's Division of Cancer Epidemiology, Core Genotyping Facility, and Office of Cancer Genomics will coordinate the project.
CGEMS data will be available via NCI's caBIG project.